Asensus Surgical Inc (ASXC): Enterprise Value to EBITDA Ratio
Asensus Surgical, Inc. (ASXC) faces intense pressure from market leaders and prolonged certification processes for new products, resulting in a significant capital deficit. This price chart, curated by Anthony Fernando's team, demonstrates management's commitment to integrating intelligent algorithms into laparoscopy. The EV/EBITDA ratio stands at , yet weak system demand and massive production costs limit the business's growth potential.
Comprehensive metric breakdowns and analytics for asensus.com (ASXC)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
ASXC - Net Financial Result|Projected Future Earnings Asensus Surgical, Inc.|ASXC - Price to Earnings Ratio|Forward P/E Multiple Asensus Surgical|ASXC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ASXC|ASXC - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Asensus Surgical|ASXC - Earnings per share for the trailing year|Quarterly EPS earnings growth asensus.com|ASXC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Asensus Surgical, Inc.
Analysis of all company metrics:TransEnterix ASXC
The ratio correlates the total enterprise value, including debt, with its operating profit before depreciation and amortization. This metric reflects the actual volatility of assets and the quality of capital management over time. For Asensus Surgical, Inc. (ASXC), this calculation is critical due to the dependence of revenues on clinics' capital expenditures for robotics, making the EV/EBITDA trend of this capital-intensive business a key indicator of the company's investment maturity.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio STRATA Skin (SSKN)|EV/EBITDA Multiple GCTK|NAOV - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Venus Concept VERO|NUWE: Enterprise Value to Operating Income Before Depreciation|AEMD: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|cutera.com (CUTR) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|Inari Medical Inc (NARI) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NVRO|RSLS - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
